News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,605 Results
Type
Article (39684)
Company Profile (247)
Press Release (658674)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204161)
Career Advice (2007)
Deals (35416)
Drug Delivery (95)
Drug Development (81048)
Employer Resources (172)
FDA (16178)
Job Trends (14856)
News (345177)
Policy (32535)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (84)
Alliances (49427)
ALS (88)
Alzheimer's disease (1376)
Antibody-drug conjugate (ADC) (124)
Approvals (16184)
Artificial intelligence (250)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (278)
Cancer (2248)
Cardiovascular disease (173)
Career advice (1675)
Career pathing (30)
CAR-T (150)
Cell therapy (419)
Cervical cancer (19)
Clinical research (65972)
Collaboration (832)
Compensation (524)
Complete response letters (19)
COVID-19 (2588)
CRISPR (39)
C-suite (240)
Cystic fibrosis (100)
Data (2193)
Decentralized trials (2)
Denatured (18)
Depression (42)
Diabetes (268)
Diagnostics (6367)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86559)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (112333)
Executive appointments (718)
FDA (17418)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (746)
Gene editing (103)
Generative AI (19)
Gene therapy (299)
GLP-1 (704)
Government (4414)
Grass and pollen (4)
Guidances (55)
Healthcare (18814)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (114)
Indications (29)
Infectious disease (2730)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16507)
IRA (40)
Job creations (3630)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (465)
Leadership (16)
Legal (7909)
Liver cancer (75)
Lung cancer (320)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (302)
MASH (66)
Medical device (13375)
Medtech (13380)
Mergers & acquisitions (19451)
Metabolic disorders (678)
Multiple sclerosis (79)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1907)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Northern California (2664)
Now hiring (39)
Obesity (361)
Opinion (204)
Ovarian cancer (75)
Pain (85)
Pancreatic cancer (83)
Parkinson's disease (148)
Partnered (21)
Patents (231)
Patient recruitment (108)
Peanut (46)
People (57288)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20547)
Phase II (29054)
Phase III (21645)
Pipeline (1178)
Policy (137)
Postmarket research (2563)
Preclinical (8735)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5907)
Recruiting (65)
Regulatory (22268)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (68)
Series A (129)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2284)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3575)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (37)
The Weekly (29)
United States (22926)
Vaccines (684)
Venture capitalists (41)
Weight loss (231)
Women's health (35)
Worklife (15)
Date
Today (153)
Last 7 days (849)
Last 30 days (2622)
Last 365 days (32881)
2025 (10483)
2024 (35218)
2023 (40077)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35019)
2017 (32110)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29265)
2010 (27330)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (37838)
Australia (6187)
California (6075)
Canada (2004)
China (520)
Colorado (265)
Connecticut (272)
Delaware (146)
Europe (81226)
Florida (904)
Georgia (204)
Idaho (57)
Illinois (528)
India (25)
Indiana (306)
Iowa (11)
Japan (159)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (886)
Massachusetts (4530)
Michigan (216)
Minnesota (388)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1712)
New Mexico (28)
New York (1728)
North Carolina (961)
North Dakota (8)
Northern California (2664)
Ohio (202)
Oklahoma (14)
Oregon (34)
Pennsylvania (1369)
Puerto Rico (12)
Rhode Island (33)
South America (1096)
South Carolina (22)
South Dakota (1)
Southern California (2284)
Tennessee (101)
Texas (899)
Utah (180)
Virginia (143)
Washington D.C. (61)
Washington State (549)
West Virginia (3)
Wisconsin (53)
698,605 Results for "icad inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
iCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025
March 12, 2025
·
3 min read
iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference
iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, announced today the Company will present at the MedInvest MedTech, AI & Digital Healthcare Conference on June 11-12, 2024 in San Francisco, CA.
June 4, 2024
·
3 min read
Press Releases
iCAD Pre-Announces Estimated Q4 2024 Revenue
January 27, 2025
·
5 min read
Business
iCAD Reports Financial Results for First Quarter Ended March 31, 2024
iCAD, Inc. today reported its financial and operating results for the three months ended March 31, 2024.
May 15, 2024
·
17 min read
Business
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
iCAD, Inc. (NASDAQ: ICAD) today announced results for its fiscal fourth quarter and full year ended December 31, 2023, as compared to the corresponding period of the last fiscal year.
March 12, 2024
·
21 min read
Pharm Country
iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare
iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced that key artificial intelligence (AI) powered solutions from iCAD’s ProFound Breast Health Suite are the first applications to be offered in GE HealthCare’s new MyBreastAI Suite* offering.
November 28, 2023
·
4 min read
Business
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
iCAD, Inc. (NASDAQ: ICAD) announced today the Company will release financial results for the fourth quarter and full year 2023 financials after the market close, and host a conference call at 4:30 PM Eastern Time on Tuesday, March 12, 2024.
February 27, 2024
·
3 min read
Press Releases
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference
November 6, 2024
·
3 min read
Press Releases
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024
November 6, 2024
·
3 min read
Business
iCAD Expands Executive Sales Leadership Team as Business Grows
iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, announced the expansion of its sales leadership with the addition of Peter Graham, as Senior Vice President, North American Sales and a role change for Bill Keyes to Senior Vice President, Global Sales Operations, both effective immediately.
December 18, 2023
·
2 min read
1 of 69,861
Next
